Standpoint Research Downgrades United Therapeutics Corp. (UTHR) to Hold
Tweet Send to a FriendGet Alerts UTHR Hot Sheet
Price: $67.49 -0.49%
Rating Summary:
3 Buy, 13 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 19 | New: 29
Rating Summary:
3 Buy, 13 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 19 | New: 29
Trade UTHR Now!
Standpoint Research downgraded United Therapeutics Corp. (NASDAQ: UTHR) from Buy to Hold.
The firm comments, "Our March 12 recommendation UTHR has jumped 40% since April 18 and just hit a 52-week high. The shares have out-performed the S&P-500 by more than 1500 bps since our recommendation. We can no longer leave our highest recommendation attached to this name. Our price target for 2013-2014 remains $60-$65."
For an analyst ratings summary and ratings history on United Therapeutics Corp. click here. For more ratings news on United Therapeutics Corp. click here.
Shares of United Therapeutics Corp. closed at $53.75 yesterday, with a 52 week range of $36.55-$55.59.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm comments, "Our March 12 recommendation UTHR has jumped 40% since April 18 and just hit a 52-week high. The shares have out-performed the S&P-500 by more than 1500 bps since our recommendation. We can no longer leave our highest recommendation attached to this name. Our price target for 2013-2014 remains $60-$65."
For an analyst ratings summary and ratings history on United Therapeutics Corp. click here. For more ratings news on United Therapeutics Corp. click here.
Shares of United Therapeutics Corp. closed at $53.75 yesterday, with a 52 week range of $36.55-$55.59.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Exane BNP Paribas Downgrades BlackBerry (BBRY) to Underperform; Analyst Says Profit 'Drying Up'
- Goldman Sachs Downgrades Patterson-UTI Energy (PTEN) to Sell
- JPMorgan Downgrades Devon Energy (DVN) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Standard & Poor's, Standpoint Research
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
